CAITLIN WALKER: Open Payments
NPI 1205468238 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 79 payments from 13 companies in 2025. Trend: 2023 $1,062 · 2024 $1,277 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $324 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $220 |
| Novo Nordisk Inc | 7 | $151 |
| Esperion Therapeutics, Inc. | 9 | $135 |
| Novartis Pharmaceuticals Corporation | 6 | $110 |
| Alnylam Pharmaceuticals Inc. | 6 | $104 |
| SCPHARMACEUTICALS INC. | 4 | $77 |
| PFIZER INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Boston Scientific Corporation | 1 | $41 |
Products named: REPATHA, Kerendia, NEXLETOL, ONPATTRO, LEQVIO, Wegovy, FUROSCIX, Ozempic.
Industry payments across NC — which companies pay providers there.
